Notification of transactions by persons discharging managerial responsibilities and persons closely associated Mediclinic International PLC (the "Company") (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 5 December 2016 NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM Mediclinic announces that on 5 December 2016 Dr Edwin Hertzog, Chairman of the Company, transferred an aggregate of 3,360,579 ordinary shares of 10 pence each in the capital of the Company from Elstelm Beleggings (Pty) Ltd to entities controlled by his children with effect from 1 December 2016. Following the transfer, the aggregate beneficial interest of Dr Hertzog and his family remains unchanged at 3,754,855, representing 0.51% of the Company’s issued share capital. The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail 1. Details of PDMR / person closely associated with them (“PCA”) a) Name Elstelm Beleggings (Pty) Ltd 2. Reason for the notification a) Position / status Investment company of Dr Edwin Hertzog, Chairman of the Company b) Initial notification / Initial Notification amendment 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Mediclinic International plc b) LEI N/A 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the Ordinary Shares financial instrument Identification Code GB00B8HX8Z88 b) Nature of the Transfer of shares transaction c) Price(s) and Price(s) Volume(s) volume(s) ZAR 419 064 201.30 3,360,579 d) Aggregated information Aggregated volume 3,360,579 Price ZAR 124.70 per share e) Date of the 5 December 2016 transaction f) Place of the Johannesburg Stock Exchange transaction Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom Website: www.mediclinic.com JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited) NSX sponsor: Simonis Storm Securities (Pty) Ltd For further information please contact: Mediclinic International plc James Arnold, Head of Investor Relations ir@mediclinic.com Capita Company Secretarial Services Limited Victoria Dalby +44 (0)207 954 9600 Date: 05/12/2016 03:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.